thromboxane-a2 and phenylalanyl-prolyl-arginine-chloromethyl-ketone

thromboxane-a2 has been researched along with phenylalanyl-prolyl-arginine-chloromethyl-ketone* in 1 studies

Other Studies

1 other study(ies) available for thromboxane-a2 and phenylalanyl-prolyl-arginine-chloromethyl-ketone

ArticleYear
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
    Cellular signalling, 2018, Volume: 48

    Tumor cell-induced platelet aggregation represents a critical process both for successful metastatic spread of the tumor and for the development of thrombotic complications in cancer patients. To get further insights into this process, we investigated and compared the molecular mechanisms of platelet aggregation induced by two different breast cancer cell lines (MDA-MB-231 and MCF7) and a colorectal cancer cell line (Caco-2). All the three types of cancer cells were able to induce comparable platelet aggregation, which, however, was observed exclusively in the presence of CaCl

    Topics: Amino Acid Chloromethyl Ketones; Aspirin; Blood Platelets; Breast Neoplasms; Caco-2 Cells; Calcium Chloride; Colorectal Neoplasms; Female; Fibrin; Fibrinogen; Humans; Integrin alpha2; MCF-7 Cells; Platelet Activation; Platelet Aggregation; Thromboxane A2; Type C Phospholipases

2018